RECENT NEWS

Diatron, a STRATEC brand specialising in the development, manufacturing, and marketing of haematology and clinical chemistry analysers and related reagents for human and veterinary use, has expanded the capabilities of its Aquila, Aquarius 3, and Abacus 5 analysers with six advanced haematological indices.

Thermo Fisher Scientific has announced that it has signed a definitive agreement to sell its microbiology business to Astorg, a leading pan-European private equity firm, for consideration of approximately $1.075 billion.

Researchers have delivered the UK’s first dose in a new trial using an investigational mRNA vaccine to protect people against potential influenza pandemics such as avian flu - also known as ‘bird flu’.

New independent modelling shows that deploying fast identification and antimicrobial susceptibility testing early in the patient pathway could prevent around 10,000 sepsis cases and 5,200 deaths in the UK every year, as well as saving the NHS approximately £300 million annually.

A new UK-wide research collaboration speeding up development of promising new treatments and precision diagnostics for Parkinson’s disease and other neurological disorders has been launched.

An international team of researchers has identified an East African bat coronavirus capable of entering human cells.

Researchers have developed an artificial intelligence tool that helps doctors more accurately measure a key marker used to decide which lung cancer patients might benefit from certain treatments.

The Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority (HRA) have launched the largest package of reforms to clinical trials in over 20 years, aiming to help UK patients get access to new treatments faster.

Launched by new IBMS President Dr Sarah Pitt in January, the new strategy for 2026–2029 has the subtitle ‘Strengthening visibility, promoting value and championing biomedical science’. It sets out a clear direction for the organisation and the profession over the next three years.

The 41st Annual Microbiology Conference of the British Society for Microbial Technology takes place on Thursday 21 May 2026 at the Royal Air Force Museum, Hendon.

Antibody and protein development firm Leinco Technologies and CellCarta, a provider of precision medicine laboratory services, have announced a strategic collaboration aimed at advancing proteomics solutions that will benefit the development of immuno-oncology and other targeted therapeutic modalities.

New figures show that NHS screening for bowel cancer is now reaching millions more people compared to a decade ago. Almost 7 million people have had bowel screening from the NHS during 2024/25, compared to around 4.7 million in 2014/15.

Roche has completed a deal to acquire SAGA Diagnostics worth almost $600 million, adding the firm’s Pathlight platform to its diagnostics portfolio.

Analysis of microbes in the gut can reveal whether a person faces an elevated risk of Parkinson’s disease before they have developed any symptoms, suggests a new study led by University College London (UCL) researchers.

A new UK Health Security Agency (UKHSA) study shows the maternal respiratory syncytial virus (RSV) vaccination programme is providing over 80% protection for newborn infants, including those born prematurely.

A new study shows variant allele frequency measured from CSF may support diagnosis and monitoring in leptomeningeal disease.

Bruker’s Microbiology and Infection Diagnostics division has launched the MyGenius PRO fully automated, sample-to-answer molecular diagnostics system in Europe.

Molecular diagnostics firm Cepheid and Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology for real-time genomic analysis, have announced an expansion of their partnership to develop a workflow for rapid bacterial and fungal pathogen identification.

Waters Corporation has announced that the BD BACTEC FXI Culture System - a next-generation, fully automated blood culture system designed to improve the speed, consistency, and accuracy of bloodstream infection diagnostics - has received CE marking under the EU’s IVDR.

US life science firm Bio-Techne Corporation has announced a streamlined brand architecture designed to enable scientists and clinicians to more easily find the answers they need based on their application and stage of research including a new diagnostics brand.